Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS

Molecular Cancer Research

Volumn 9, Issue 6, 2011, Pages 746-756

  Mordasky Markell, Lauren ^a   Masiuk, Katelyn E ^a   Blazanin, Nicholas ^a   Glick, Adam B ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN; CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN 1A; CORNIFIED ENVELOPE LIKE PROLINE RICH PROTEIN 2H; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOXYCYCLINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; GROWTH DISORDER; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE;

ANIMALS; BENZAMIDES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIOXOLES; GENES, RAS; HUMANS; KERATINOCYTES; MICE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSGLUTAMINASES;

MUS MUSCULUS;

EID: 79959230184     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0112     Document Type: Article

References (41)

1. Fowlis DJ, Cui W, Johnson SA, Balmain A, Akhurst RJ. Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor β1 in the skin of transgenic mice. Cell Growth Differ 1996;7:679-87. (Pubitemid 26360766)
2. Blessing M, Nanney LB, King LE, Hogan BL. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-β related transgene. Teratog Carcinog Mutagen 1995;15:11-21. (Pubitemid 126684648)
3. Honjo Y, Bian Y, Kawakami K, Molinolo A, Longenecker G, Boppana R, et al. TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. Cell Cycle 2007;6:1360-6. (Pubitemid 47327971)
4. Bian Y, Terse A, Du J, Hall B, Molinolo A, Zhang P, et al. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res 2009;69:5918-26.
5. Amendt C, Schirmacher P, Weber H, Blessing M. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 1998;17:25-34. (Pubitemid 28360526)
6. Goudie DR, D'Alessandro M, Merriman B, Lee H, Szeverenyi I, Avery S, et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet 2011;43:365-9.
7. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-42. (Pubitemid 26299485)
8. Weeks BH, He W, Olson KL, Wang XJ. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res 2001;61:7435-43. (Pubitemid 32995031)
9. Mordasky Markell L, Perez-Lorenzo R , Masiuk KE , Kennett MJ , Glick AB. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis 2010;31:2127-35.
10. Glick AB. TGFbeta1, back to the future: revisiting its role as a transforming growth factor. Cancer Biol Ther 2004;3:276-83. (Pubitemid 41350879)
11. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-89. (Pubitemid 24108054)
12. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A. Defects in TGFbsignaling overcome senescence of mouse keratinocytes expressing v-ras. Oncogene 2000;19:1698-709. (Pubitemid 30200972)
13. Dlugosz AA, Cheng C, Williams EK, Dharia AG, Denning MF, Yuspa SH. Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. Cancer Res 1994;54:6413-20.
14. Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH. Isolation and utilization of epidermal keratinocytes for oncogene research. In: Vogt PK, Verma IM, editors. Methods in enzymology. New York: Academic Press; 1995. p. 3-20.
15. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999;400:468-72. (Pubitemid 29361802)
16. Diamond I, Owolabi T, Marco M, Lam C, Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 2000;115:788-94.
17. Hough-Monroe L, Milstone LM. Quantitation of cross-linked protein: an alternative to counting cornified envelopes as an index of keratinocyte differentiation. Anal Biochem 1991;199:25-8.
18. Nagae S, Lichti U, De Luca LM, Yuspa SH. Effect of retinoic acid on cornified envelope formation: difference between spontaneous envelope formation in vivo or in vitro and expression of envelope competence. J Invest Dermatol 1987;89:51-8. (Pubitemid 17084184)
19. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.
20. Jaubert J, Patel S, Cheng J, Segre JA. Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epidermal conditional gene expression. J Invest Dermatol 2004;123:313-8. (Pubitemid 38951826)
21. Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A. Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci U S A 2001;98:9139-44. (Pubitemid 32743882)
22. Eckert RL, Crish JF, Robinson NA. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997;77:397-424. (Pubitemid 27184344)
23. Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, et al. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 2004;25:1771-8. (Pubitemid 39214320)
24. Wikner NE, Elder JT, Persichitte KA, Mink P, Clark RA. Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro. J Invest Dermatol 1990;95:607-13.
25. Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 1980;40:4694-703. (Pubitemid 11199740)
26. Kulesz-Martin M, Kilkenny AE, Holbrook KA, Digernes V, Yuspa SH. Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation. Carcinogenesis 1983;4:1367-77. (Pubitemid 14249312)
27. Yuspa SH, Kilkenny AE, Stanley J, Lichti U. Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses. Nature 1985;314:459-62. (Pubitemid 15145589)
28. Yuspa SH, Vass W, Scolnick E. Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. Cancer Res 1983;43:6021-30. (Pubitemid 14212675)
29. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM. Regulation of transglutaminase type II by transforming growth factor-β 1 in normal and transformed human epidermal keratinocytes. J Biol Chem 1990;265:11098-104.
30. Reiss M, Sartorelli AC. Regulation of growth and differentiation of human keratinocytes by Type β transforming growth factor and epidermal growth factor. Cancer Res 1987;47:6705-9. (Pubitemid 18019674)
31. Saunders NA, Jetten AM. Control of growth regulatory and differentiation- specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem 1994;269:2016-22. (Pubitemid 24035408)
32. Dahler AL, Cavanagh LL, Saunders NA. Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways. J Invest Dermatol 2001;116: 266-74. (Pubitemid 32173731)
33. Reiss M, Zhou ZL. Uncoupling of the calcium-induced terminal differentiation and the activation of membrane-associated transglutaminase in murine keratinocytes by type-beta transforming growth factor. Exp Cell Res 1989;183:101-11. (Pubitemid 19166513)
34. Vijayachandra K, Lee J, Glick AB. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res 2003;63:3447-52. (Pubitemid 36793018)
35. Vijayachandra K, Higgins W, Lee J, Glick A. Induction of p16(ink4a) and p19(ARF) by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol Carcinog 2009;48: 181-6.
36. Yuspa SH, Ben T, Hennings H, Lichti U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1982;42:2344-9. (Pubitemid 12121455)
37. Kobielak K, Pasolli HA, Alonso L, Polak L, Fuchs E. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol 2003;163:609-23. (Pubitemid 37429873)
38. Kobielak K, Stokes N, de la CJ, Polak L, Fuchs E. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling. Proc Natl Acad Sci U S A 2007;104:10063-8. (Pubitemid 47175263)
39. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010;10:51-7.
40. Tsuchida K, Nakatani M, Uezumi A, Murakami T, Cui X. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocr J 2008;55:11-21. (Pubitemid 351520175)
41. Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, et al. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 2004;64:7954-61. (Pubitemid 39446929)